128 related articles for article (PubMed ID: 34512018)
1. Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events.
Zhou H; Zou M; Ding X; Zou F
Cancer Manag Res; 2021; 13():6785-6795. PubMed ID: 34512018
[TBL] [Abstract][Full Text] [Related]
2. BCLAF1 promotes cell proliferation, invasion and drug-resistance though targeting lncRNA NEAT1 in hepatocellular carcinoma.
Mou SJ; Yang PF; Liu YP; Xu N; Jiang WW; Yue WJ
Life Sci; 2020 Feb; 242():117177. PubMed ID: 31870774
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma.
Yan H; Wu X; Li H; Yu Z; Jin X
Biochem Genet; 2024 Apr; ():. PubMed ID: 38573525
[TBL] [Abstract][Full Text] [Related]
4. Heat Shock Protein 90α-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene c-MYC mRNA Stability.
Zhou X; Wen Y; Tian Y; He M; Ke X; Huang Z; He Y; Liu L; Scharf A; Lu M; Zhang G; Deng Y; Yan Y; Mayer MP; Chen X; Zou F
Hepatology; 2019 Apr; 69(4):1564-1581. PubMed ID: 30015413
[TBL] [Abstract][Full Text] [Related]
5. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
6. Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1.
Yang M; Hu C; Cao Y; Liang W; Yang X; Xiao T
Front Pharmacol; 2020; 11():622212. PubMed ID: 33628185
[No Abstract] [Full Text] [Related]
7. Screening and identification of key biomarkers in adrenocortical carcinoma based on bioinformatics analysis.
Xing Z; Luo Z; Yang H; Huang Z; Liang X
Oncol Lett; 2019 Nov; 18(5):4667-4676. PubMed ID: 31611976
[TBL] [Abstract][Full Text] [Related]
8. The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.
Brown GT; Cash B; Alnabulsi A; Samuel LM; Murray GI
Histopathology; 2016 Mar; 68(4):556-66. PubMed ID: 26183150
[TBL] [Abstract][Full Text] [Related]
9. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
Yan ZC; He L; Qiu JH; Deng WT; Lu JR; Yuan Z; Liu DJ; Zheng RQ; Jiang W
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6640-6649. PubMed ID: 30402836
[TBL] [Abstract][Full Text] [Related]
11. New insights from Whole Genome Sequencing: BCLAF1 deletion as a structural variant that predisposes cells towards cellular transformation.
Mwapagha LM; Chibanga V; Shipanga H; Parker MI
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34490482
[TBL] [Abstract][Full Text] [Related]
12. BCLAF1 induces cisplatin resistance in lung cancer cells.
Jiang T; Liu B; Wu D; Zhang F
Oncol Lett; 2020 Nov; 20(5):227. PubMed ID: 32968449
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
[TBL] [Abstract][Full Text] [Related]
14. Identification of Five Genes as a Potential Biomarker for Predicting Progress and Prognosis in Adrenocortical Carcinoma.
Xiao H; Xu D; Chen P; Zeng G; Wang X; Zhang X
J Cancer; 2018; 9(23):4484-4495. PubMed ID: 30519354
[TBL] [Abstract][Full Text] [Related]
15. BCLAF1 is Expressed as a Potential Anti-oncogene in Bile Duct Cancer.
Zhou Y; Ran X; Han M
Biochem Genet; 2024 Jan; ():. PubMed ID: 38198022
[TBL] [Abstract][Full Text] [Related]
16. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
[TBL] [Abstract][Full Text] [Related]
17. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y; Fan Y
Tumour Biol; 2016 Jun; 37(6):7371-81. PubMed ID: 26676636
[TBL] [Abstract][Full Text] [Related]
18. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Bcl-2-associated transcription factor 1 in the differentiation of early-born retinal cells.
Orieux G; Picault L; Slembrouck A; Roger JE; Guillonneau X; Sahel JA; Saule S; McPherson JP; Goureau O
J Neurosci; 2014 Jan; 34(4):1530-41. PubMed ID: 24453340
[TBL] [Abstract][Full Text] [Related]
20. B-cell lymphoma-2-associated transcription factor 1 is overexpressed and contributes to sorafenib resistance in hepatocellular carcinoma.
Yu S; Wang X; Dou N; Zhou J; Gao Y; Li Y
Hepatol Res; 2019 Nov; 49(11):1329-1340. PubMed ID: 31237058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
